Eradication of Pseudomonas aeruginosa Biofilms by Atmospheric Pressure Non-Thermal Plasma
Comparing inhibitory effect of tramadol on catalase of Pseudomonas aeruginosa and mouse liver
-
Upload
independent -
Category
Documents
-
view
0 -
download
0
Transcript of Comparing inhibitory effect of tramadol on catalase of Pseudomonas aeruginosa and mouse liver
Comparing inhibitory effect of tramadol on
catalase of Pseudomonas aeruginosa and mouse liver
Running title: Tramadol and catalase inhibition
Dariush Minai-Tehrani*, Imana Sadat Ashrafi, Mina
Kolahdoz Mohammadi, Zahra Sobhani Damavandifar, Elmira
Rezaei Zonouz, Tahmineh Ebrahimzadeh Pirshahed
* Corresponding author: Dariush Minai-Tehrani (PhD)
BioResearch Lab, Faculty of Biological Sciences, Shahid
Beheshti University, G.C. Iran.
Email: [email protected]
Tel: +98-21-29903144
Fax: +98-21-22431664
Number of words: 2736
Number of figures: 5
Number of tables: 0
Number of references: 19
1
Abstract
Tramadol is an analgesic drug that binds to specific
opioid receptors. It may contribute to the inhibition of
neuronal re-uptake of noradrenaline. Catalase is a key
enzyme for degrading H2O2 in cells and has various
isoforms with different structures and kinetics
properties. In this research, the effect of tramadol on
the activity of catalase of Pseudomonas and mouse liver
was investigated and compared. Tramadol could inhibit
Pseudomonas catalase with mixed inhibition while
inhibiting mouse liver catalase in a non-competitive
manner. The Ki and IC50 values were determined as 0.45 and
1.5 mM for Pseudomonas and 2.8 and 2.5 mM for mouse liver,
respectively. SDS-PAGE of partially purified catalases
determined different molecular weights for Pseudomonas (Mw
54 kDa) and mouse liver (61 kDa).
Keywords: Drug, Enzyme, Inhibition, Mouse liver,
Bacteria.
2
Introduction
Tramadol is a centrally acting synthetic opioid analgesic
which possesses opioid agonist properties and activates
monoaminergic spinal inhibition of pain. It may be
administered orally, rectally, intravenously or
intramuscularly [1, 2]. The drug may become a useful
alternative for the opioid analgesics which are currently
available for the treatment of patients with moderately
severe acute or chronic pain [1].
Experimental and clinical data have suggested that
tramadol may also exert its analgesic effect through
direct modulation of central monaminergic pathways [2].
Clinical experience has confirmed that tramadol is an
effective and relatively safe analgesic that may be of
value in several pain conditions, not requiring treatment
with strong opioids [2]. Tramadol is a synthetic analogue
of codeine that binds to mu opiate receptors and inhibits
norepinephrine and serotonin reuptake [3].
Tramadol has dose- and time-dependent bactericidal
activity against E. coli and S. epidermidis as well as
antibacterial activity against S. aureus and P. aeruginosa [4-
3
6]. It also possesses a significant antibacterial
activity against E. coli in urinary tract infections [6].
Catalase (CAT) (EC 1.11.1.6) is a heme containing enzyme
that catalyzes decomposition of hydrogen peroxide to
water and oxygen and is found in almost all cells, except
certain anaerobic bacteria. Bovine CAT was one of the
first enzymes to be isolated up to a high state of purity
and the first iron-containing enzyme which was isolated
[7]. CAT has many varieties in different organisms. Most
of catalases are monofunctional which only decompose H2O2.
Others are bifunctional catalase-peroxidases and
manganese-containing catalases [8].
H2O2 is a potent oxidative agent and is normally produced
during cell metabolism. H2O2 can damage the cells through
oxidation of nucleic acids, unsaturated lipids and
proteins [9]. CAT plays a main role for removing H2O2 and
preventing cell injures. The CAT activity can be affected
by some compounds; consequently, the cells may be injured
due to change of H2O2 concentration.
It has been shown that some chemicals and drugs inhibit
CAT activity. Some heavy metals such as copper inhibit
4
CAT with a non-competitive pattern [10] and cyanide acts
as a competitive inhibitor [11, 12]. The inhibition of
CAT by nitric oxide and relationship of this effect with
nitric oxide cytotoxicity were also investigated [13].
Some drugs have been also found to have an inhibitory
effect on CAT activity. Human skin CAT activity was
inhibited by vesnarinone, piroxicam, ketoprofen,
diclofenac sodium and nidazole [14, 15].
Although there are some reports on the CAT inhibition by
drug, there is no work on the kinetic aspects of drugs'
action on CAT.
In this report, for the first time, tramadol was
introduced as an inhibitor for CAT and also the kind of
inhibition and kinetics parameters of interaction was
determined. Besides, a comparison of the interaction of
tramadol between CAT in Pseudomonas aeruginosa and mouse
liver was investigated, which opened a new view to
understanding the behavioral difference between isoforms
of the enzyme.
Materials and Methods
5
All the chemicals used for buffers' preparation, enzyme
assay and electrophoresis were purchased from Merck
Company. DEAE cellulose and tramadol hydrochloride were
provided from Sigma Company. Sephadex G-100 was obtained
from Pharmacia Company.
Preparing cell free extract
Balb/C mouse liver was sliced to small pieces and washed
with NaCl (9 g/L) solution. The mouse liver pieces were
homogenized and centrifuged (for 10 min at 3000 × g) to
remove intact cells. The supernatant was used as the cell
free extract for enzyme assay.
Pseudomonas aeruginosa (ATCC 31479) was cultured in the
minimal medium containing 2.5 g KH2PO4, 2.5 g Na2HPO4, 1 g
NH4NO3, 0.2 g MgSO4 and 0.01 g CaCO3 per liter adjusted to
pH 7.0. Ethanol was added to this medium to the final
concentration of 1% (v/v) as a carbon source. The
bacteria were cultured for 72 h in a reciprocal shaker at
150 rpm at 30°C. After 72 h (in the stationary phase),
the medium was centrifuged (5000 × g for 30 min) to
precipitate cells. The precipitated cells were washed
6
twice with phosphate buffer 0.1 M, pH = 7 and centrifuged
(7000 × g, 30 min at 25°C). The pellet was dissolved in
the phosphate buffer to obtain cell suspension. To break
the cells, bacteria suspension was sonicated for 5 × 20
sec with 20 sec intervals at 4°C. The sonicated
suspension was centrifuged (12000 × g for 30 min at 0-
4°C) to precipitate intact cells. The supernatant was
used as the cell-free extract for further experiments.
Enzyme assay
H2O2 was used as substrate to measure CAT activity.
Tramadol was prepared with concentrations ranging from
0.65 to 3.8 mM as an inhibitor. The reaction was started
by adding 100 μl of the cell-free extract which contained
CAT to test tubes containing 0.1 M phosphate buffer (pH =
7) and different concentrations of H2O2 as substrate (1 -
8 mM) for 10 min in the presence and absence of tramadol.
The final volume in each test tube was always 2.2 ml. The
catalytic activity of CAT was monitored continuously by
following the decrease in absorption at 240 nm using a
UV-visible spectrophotometer (Shimadzu 1240). CAT
7
activity was measured using the extinction coefficient of
43.6 M−1 cm−1 for H2O2 at 240 nm [16]. Lineweaver-Burk plot
was used to obtain Km and Vmax of the enzyme. The reaction
rate of the enzyme was also examined at different pHs (3,
4, 5, 6, 7, 8, 9, 10, 11 and 12). Different buffer
systems including glycine, phosphate, acetate and Tris
were used to obtain 0.1 M buffer in which pH varied from
3 to 12.
Partial purification of enzyme
The cell-free extract from mouse liver and Pseudomonas
were brought to 50% ammonium sulfate saturation. The
precipitate was collected by being centrifuged at 5000
g for 10 min and dissolved in 0.1 M phosphate buffer (pH
= 7). The suspension was dialyzed against phosphate
buffer overnight. All the above procedures were performed
at 4°C. The dialyzed suspension was loaded onto a DEAE
cellulose column equilibrated by 50 mM Tris buffer (pH =
8). Elution was performed by increasing NaCl
concentration at the flow rate of 1 ml/min. The fractions
were monitored for the amount of protein (at 280 nm
8
absorption) and enzyme activity. The fraction with
maximum activity was selected for gel filtration
chromatography which was performed by Sephadex G-100. The
fractions with maximum activity were selected for SDS-
PAGE electrophoresis.
Results
Inhibition pattern
The reaction rate of CAT was determined in the absence
and presence of tramadol by monitoring the reduction of
substrate (H2O2) at 240 nm. The incubation of enzyme with
H2O2 continued to reach the plateau (substrate depletion).
In the presence of tramadol, the reaction rate of enzyme
in both mouse and bacterium was reduced which determined
that the drug inhibited the enzyme activity. Lineweaver-
Burk plot was applied to find out the inhibition pattern.
The inhibition in bacterium was different from that in
mouse CAT. Tramadol inhibited Pseudomonas CAT with mixed
pattern (Fig. 1 left) while it inhibited mouse liver CAT
with constant Km (non-competitive) (Fig. 1 right).
The Km of enzyme was increased by increasing tramadol
concentration and IC50 value was determined to be 1.6 mM
9
in Pseudomanas (Fig. 2 left). In mouse liver, Vmax of the
enzyme decreased by increasing the drug concentration and
the IC50 value was about 2.4 mM (Fig. 2 right). The slope
of lines and the intercepts from Lineweaver–Burk plot
were used to determine the Ki of the inhibitor in
Pseudomonas (0.45 mM) and mouse liver (2.8 mM),
respectively (Fig. 3).
pH profile
The effect of pH on CAT activity was compared in
Pseudomonas and mouse liver (Fig. 4). Both CATs had the
maximum activity at pH 7. In mouse liver, another peak
was observed at pH of 9 and the activity was suddenly
decreased at pH of 10. In Pseudomonas, there was another
peak at pH=10 and the enzyme remained active at pH=11;
but, no activity was observed at pH=12.
SDS-PAGE
SDS-PAGE was performed to compare the mobility and
molecular weight difference between the two CATs. The
molecular weight of bacterium CAT was determined to be
10
about 54 kDa while the CAT of mouse liver was calculated
to be 61 kDa (Fig. 5).
The specific activity of partial purified enzyme was
determined to be 9.65 and 28.5 U/mg protein in Pseudomonas
and mouse liver respectively.
Discussion
Tramadol is a narcotic-like pain reliever drug which is
widely used to treat moderate to severe pains. One of the
most important precautions for drug consumption is drug
side effect that can affect body physiology. Most of the
drugs may interact with receptors or enzymes other than
the targets for which they have been designed [17, 18].
In this regard, it was shown that cimetedine inhibited
renal alkaline phosphatase with un-competitive manner
[17]. This report focused on the effect of tramadol on
the activity of CAT. In this research, the inhibitory
effect of tramadol on CAT activity was reported for the
first time and the kinetics aspects of interaction were
determined in Pseudomonas and mouse liver. Mouse liver was
chosen as a model for eukaryotic CAT and was compared
with Pseudomonas as a model for prokaryotic cells.
11
Although the effect of some drugs such as piroxicam,
ketoprofen, diclofenac sodium and nidazole on human skin
CAT has been reported [15], no reports has indicated the
kinetics aspect of inhibition. It was shown that CAT had
various isozyme in animals, plants and microorganisms,
which had various structure and properties [8, 19].
The present results showed that tramadol could inhibit
CAT activity and the pattern of inhibition was different
in Pseudomonas and mouse liver. Tramadol inhibited
Pseudomonas CAT with mixed pattern while it inhibited
mouse liver CAT with non-competitive manner. These
results suggested that tramadol could bind to the
bacterium and mouse liver CAT from the site other than
active site. The comparison of Ki and IC50 values of
tramadol in both of the samples showed that the drug
could bind to liver CAT with higher affinity than the
bacterium CAT. Not only the two CATs showed dissimilar
behavior in kinetics parameters but also they
demonstrated a different pattern in their pH profiles. In
high basic pH, Pseudomonas CAT was more resistant than the
mouse liver CAT. The former was active at pH=10 and 11
12
while the latter lost its activity at pH=10. This
suggested that the two CATs might have different
structures and be considered as two isoforms.
Consequently, the drug could inhibit them with different
manners. To confirm the structural difference between
these two CATs, SDS-PAGE from partial purified enzyme was
performed. The results showed that the two CATs did not
have the same mobility and had different molecular
weights. This suggested that the two enzymes had
different structures. The molecular weight of CATs
obtained from SDS-PAGE was very similar to Pseudomonas
(55kDa) and bovine liver (60kDa) molecular weight CTAs
which was reported by Switala and Loewen [19].
That report also indicated the difference kinetics
parameter of binding of some CAT inhibitors such as KCN,
NaN3 and Aminotriazole between various CATs [19].
In conclusion, this was the first report that compared
the inhibition pattern of the CAT isoform in eukaryotic
and prokaryotic cells. Tramadol was introduced as an
inhibitor of CAT and its kinetics parameters were
determined. The CAT of Pseudomonas was partially purified
13
References
1- Lee , CR .;, McTavish , D ,.; Sorkin , EM . Tramadol. A
preliminary review of its pharmacodynamic and
pharmacokinetic properties, and therapeutic potential in
acute and chronic pain states. Drugs 1993,; 46,: 313-340.
2- Dayer , P .;, Collart , L .;, Desmeules , J . The
pharmacology of tramadol. Drug 1994;, 47 Suppl 1,: 3-7.
3- Lewis, KS.;, Han, N.H.. Tramadol: a new centrally
acting analgesic. Am. J. Health Syst .Pharm. 1997,; 54,:
643-652.
4- Vo Van, J.M.;, Tamanai-Shacoori, Z.;, Shacoori, V.;,
Leroy, M.;, Bonnaure-Mallet, M., Antibacterial activity
of tramadol: preliminary study. Eur. J .Anaesthesiol.,
2006,; 23,: 148.
5- Tamanai-Shacoori, Z.;, Shacoori, V.;, Jolivet-
Gougeon, A.;, Vo Van, J.M.;, Repère, M.;, Donnio, P.Y.; ,
Bonnaure-Mallet, M . The antibacterial activity of
15
tramadol against bacteria associated with infectious
complications after local or regional anesthesia. Anesth.
Analg. 2007; 105:524-527.
6- Al-kuraishy, H.M. Possible antibacterial possessions
of tramadol hydrochloride for urinary tract infection: In
vitro study. Int. Pharmaceut. Sciencia. 2012,; 2,: 97-
102 .
7- Sumner, J.B.;, Dounce, A.L.;. Crystalline catalase. J.
Biol. Chem. 1937,; 121,: 417-424.
8- Chelikania, P, .; Fitab, I.; , Loewen, P.C. Diversity
of structures and properties among catalases. Cell. Mol.
Life. Sci. 2004,; 61,: 192–208.
9- Zhu, D.; , Tan, K.S.; , Zhang, X.; , Sun, A.Y.; ,
Grace, Y.; , Sun, G.Y.; , Lee, J.C.M. Hydrogen peroxide
alters membrane and cytoskeleton properties and increases
intercellular connections in astrocytes. J. Cell. Sci.
2005,; 118,: 3695-3703.
16
10- Ossola , J . O .; , Groppa , M . D .; , Tomaro , M . L .
Relationship between oxidative stress and heme oxygenase
induction by copper sulfate. Arch . Biochem . Biophys .
1997,; 337,: 332-337.
11- Alan, D.; , Wolfe, A.D.; , Beers, R.F.; , Sizer, I.
Cyanide inhibition of the catalase system. Arch .
Biochem . Biophys . 1957,; 73,: 353–357.
12- Maj, M.; , Nicholls, P.; , Obinger, C.; , Hillar, A.;
, Loewen, P.C. Reaction of E. coli catalase HPII with
cyanide as ligand and as inhibitor. . Biochim. Biophys.
Acta- Protein. Struct. Mol. Enzymol. 1996; , 1298: ,
241-249.
13- Brown, G.C. Reversible binding and inhibition of
catalase by nitric oxide. Eur .J .Biochem 1995,; 232,:
188-191.
17
14- Kondo , T .; , Suzuki , Y .; , Kitano , T .; , Iwai , K .; ,
Watanabe, M.;, Umehara , H , .; Daido , N .; , Domae , N .; ,
Tashima , M .; , Uchiyama , T . Vesnarinone causes oxidative
damage by inhibiting catalase function through ceramide
action in myeloid cell apoptosis. Mol . Pharmacol .
2002,; 61,: 620-627.
15- Altikat, S.; , Coban, A.; , Ciftci ,M.; , Ozdemir, H.
In vitro effects of some drugs on catalase purified from
human skin. J. Enzym. Inhib. Med. Chem. 2006,; 21,:
231–234.
16- Bienert, G.P.; , Moller, A.L.B.; , Kristiansen, K.A.;
, Schulz, A.; , Moller, I.M.; , Schjoerring, J.K.; ,
Jahn, T.P.; . Specific aquaporins facilitate the
diffusion of hydrogen peroxide across membranes. J. Biol.
Chem. 2007,; 282,: 1183-1192.
17- Minai-Tehrani D, Khodai S, Aminnaseri S, Minoui S,
Sobhani-Damavadifar Z, Alavi S, Osmani R, Ahmadi S.
18
Inhibition of renal alkaline phosphatase by cimetidine.
Drug. Metab. Lett. 2011; 5: 197-201.
18- Minai-Tehrani, D.; , Masoudnia, A.; , Alavi, S.; ,
Osmani, R.; , Lotfi, L.; , Asghari, M.; , Pirsalehi, M.;
, Sobhani-Damavandifar, Z. Interaction of methocarbamol
and yeast sucrase induces an inhibition. Drug Drug.Metab.
Drug. Interact. 2012,; 27,: 225-228.
19- Switala, J.; , Loewen, P.C. Diversity of properties
among catalases. Arch. Biochem. Biophys. 2002,; 401,:
145–154.
19
Legends:
Figure 1: Lineweaver-Burk plots were obtained for
determining the pattern of inhibition. Left: Inhibition
in Pseudomonas CAT (mixed). Right: Inhibition of mouse
liver CAT (non-competitive).
Figure 2: Determination of IC50 values in Pseudomonas CAT
(left) and mouse liver CAT (right).
Figure 3: Secondary plot derived from Lineweaver-Burk was
used for Ki determination. For Pseudomonas (mixed
inhibition) the slopes of lines (left graph) and for
mouse liver (non-compatitive) the ordinate intercept of
lines (right graph) were utilized to calculate the Ki of
tramadol.
Figure 4: Comparison of pH curves in Pseudomonas CAT and
mouse liver CAT.
Figure 5: Silver nitrate stained SDS-PAGE of partial
purified CAT of Pseudomonas and mouse liver. Lane1:
20
Protein standard, Lane 2: CAT of Pseudomonas (P), Lane 3:
CAT of mouse liver (M), Lane 4: Bovine serum albumin with
Mw 66500.
21